Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.

Kalle E Mattila,Siru Mäkelä,Soili Kytölä,Emma Andersson,Pia Vihinen, Susan Ramadan,Tanja Skyttä,Leena Tiainen,Meri-Sisko Vuoristo,Kristiina Tyynelä-Korhonen,Jussi Koivunen,Laura Kohtamäki,Kristiina Aittomäki,Micaela Hernberg

Acta oncologica (Stockholm, Sweden)（2022）

引用 0|浏览14

暂无评分

摘要

Higher pretreatment plasma ctDNA levels and sustained detectable plasma ctDNA levels during treatment indicated poor prognosis in metastatic melanoma patients.

查看译文

关键词

Biomarker,ctDNA,droplet digital PCR,melanoma,survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要